bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
2.425
+0.035 (1.46%)
At close: Nov 11, 2026, 4:00 PM EST
2.450
+0.025 (1.03%)
After-hours: Nov 11, 2026, 5:15 PM EST
bioAffinity Technologies Employees
bioAffinity Technologies had 57 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes bioAffinity Technologies the 34,376th largest employer in the world and 4,562nd in the United States.
Employees
57
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$96,933
Profits / Employee
-$270,372
Market Cap
3.11M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 57 | 0 | - |
| Dec 31, 2024 | 57 | -18 | -24.00% |
| Dec 31, 2023 | 75 | 61 | 435.71% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Burning Rock Biotech | 667 |
| MDxHealth | 364 |
| Biodesix | 334 |
| XWELL | 280 |
| Exagen | 220 |
| Precipio | 71 |
| Insight Molecular Diagnostics | 58 |
| Quantum Cyber | 13 |
BIAF News
- 9 hours ago - BioAffinity Technologies reports record CyPath Lung test performed in October - TheFly
- 9 hours ago - bioAffinity Technologies Reports Record Monthly Testing Volume in October for Its Noninvasive CyPath® Lung Test - Business Wire
- 5 days ago - bioAffinity Technologies Reports Third Quarter 2026 Results and Continued Momentum in CyPath® Lung Commercialization - Business Wire
- 5 days ago - bioAffinity Technologies Quarterly report: Q3 2026 - Filings
- 5 days ago - bioAffinity Technologies Earnings release: Q3 2026 - Filings
- 13 days ago - BioAffinity highlights importance of early lung cancer detection, treatment - TheFly
- 13 days ago - bioAffinity Technologies Highlights Importance of Link Between Early Lung Cancer Detection and Curative Treatment During National Lung Cancer Awareness Month - Business Wire
- 19 days ago - bioAffinity Technologies Proxy statement: Proxy filing - Filings